Chagas' disease: IgG isotypes against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens of Trypanosoma cruzi in chronic Chagasic patients. 2007

A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
Centro de Pesquisas Aggeu Magalhães (CPqAM)/Fiocruz, Recife-PE, Brazil.

The wide range of clinical Chagas' disease manifestations, of which heart involvement is the most significant, because of its characteristics, frequency and consequences, and lack of treatment and cure, justify research in this area. Specific immunoglobulin G (IgG) antibody subclasses have been associated with human Chagas' disease. Thus, in this study, the profile of IgG subclasses against cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive T. cruzi-specific antigens was correlated with cardiac (CARD, n=33), cardiodigestive (CD, n=7), and indeterminate (IND, n=20) forms of Chagas' disease by indirect enzyme-linked immunosorbent assay (ELISA). IgG subclasses were detected in almost all Chagas patients studied. Nevertheless, only specific IgG2 isotype FRA was found with a significant statistical difference in CARD patients when compared to IND patients. This result suggests the potential use of this isotype for prognostic purposes, for monitoring the progression of chronic Chagas' disease, and for predicting the risk of CARD damage. This is important information, as it could help physicians to evaluate and manage the treatment of their patients. However, a follow-up study is necessary to confirm our result.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000913 Antibodies, Protozoan Immunoglobulins produced in a response to PROTOZOAN ANTIGENS. Protozoan Antibodies

Related Publications

A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
May 2011, Human immunology,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
October 2010, Human immunology,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
June 2005, Parasitology research,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
April 1993, Clinical immunology and immunopathology,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
April 2024, The American journal of tropical medicine and hygiene,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
January 2003, Revista da Sociedade Brasileira de Medicina Tropical,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
April 1993, Revista medica de Chile,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
June 2001, Trends in parasitology,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
January 2001, Archivos de cardiologia de Mexico,
A F A Verçosa, and V M B Lorena, and C L Carvalho, and M F A D Melo, and M G A Cavalcanti, and E D Silva, and A G P Ferreira, and V R A Pereira, and W V Souza, and Y M Gomes
November 1992, Bio/technology (Nature Publishing Company),
Copied contents to your clipboard!